International Biotechnology Trust (LSE:IBT) Beta: 0.1328 (As of Jun. 25, 2026)


LSE:IBT International Biotechnology Trust PLC LSE:IBT
32 GF Score
Price £10.50
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust Beta?

International Biotechnology Trust LSE:IBT +1.94% 32 Beta is 0.1328 as of Jun. 25, 2026. GuruFocus rates LSE:IBT with a GF Score™ of 32/100. The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), International Biotechnology Trust's Beta is 0.1328.


International Biotechnology Trust  (LSE:IBT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


International Biotechnology Trust Beta Related Terms


International Biotechnology Trust Beta Historical Data

* Premium members only.

The historical data trend for International Biotechnology Trust's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Beta Chart

International Biotechnology Trust Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.26 0.12

International Biotechnology Trust Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.26 0.36 0.12 0.16

LSE:IBT vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, International Biotechnology Trust's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Beta distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Beta falls into.


LSE:IBT
32GF Score
International Biotechnology Trust PLC LSE:IBT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

International Biotechnology Trust Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1328 mean?
International Biotechnology Trust (LSE:IBT) has a Beta of 0.1328 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for International Biotechnology Trust and its competitors.
Is International Biotechnology Trust's Beta too high?
International Biotechnology Trust's current Beta is 0.1328. Overall, International Biotechnology Trust has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's Beta compare to VRTX and REGN?
International Biotechnology Trust's Beta of 0.1328 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for International Biotechnology Trust and its competitors. International Biotechnology Trust's current Beta is 0.1328. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current Beta of 0.1328. The current Beta is 0.1328. International Biotechnology Trust's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current Beta is 0.1328 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
32GF Score

Get the complete analysis for LSE:IBT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£10.50
Price